Secreted antibodies by plasma cells provide antigen specific humoral immunity, with long-lived plasma cells playing a critical role in immune memory responses. While recent studies have provided considerable insight into terminal differentiation of B cells into plasma cells, exactly how plasma cells are maintained long after antigen exposure remains enigmatic. Conditional gene targeting in animal models has permitted delineation of gene function and signaling networks in a cell type specific manner. Until now this technique could not be efficiently applied to plasma cells because of the lack of plasma cell specific Cre alleles. We propose to generate two strains which will allow genetic manipulation of this poorly understood lineage. Using state-of-the-art CRISPR/Cas9 gene editing approach we have knocked-in a codon optimized Cre into the IgJ locus that encodes the J chain polypeptide expressed selectively in all plasma cells. J chain polypeptide is necessary for multimerization of secreted IgM and IgA, but is expressed in all murine plasma cells. We will also generate a second Cre model, in which a codon optimized ligand inducible iCreERt2 will be knocked-into the same IgJ locus. Preliminary analysis of our first IgJ-iCre mice is highly promising, revealing plasma-cell specific expression of Cre recombinase. We will perform detailed analysis to further validate the cell specificity and efficiency of Cre activity by crossing the IgJ-iCre and IgJ-iCreERt2 mice to a reporter strain. The two plasma cell specific Cre alleles will, for the first time, provide the means to perform conditional gene targeting in this poorly understood lineage. Plasma cells play a central role in immune responses to pathogens and immunizations and are critical players in autoimmunity and cancer. These two plasma cell specific Cre lines have potential to facilitate a wide range of studies into signaling networks required for plasma cell differentiation, survival and function, multiple myeloma pathogenesis as well as genetic studies looking into the exact contribution of plasma cells to autoimmune and inflammatory diseases. The priority for our immunology lab, as outlined in Aim 2, is to investigate the role of B cell receptor (BCR) signaling and affinity of the BCR for antigen in the maintenance of long-lived plasma cells. We also intend to use the lineage tracing approach that will be made possible by the IgJ-iCreERt2 mice to characterize the differences between plasma cells that develop shortly after the immunogenic challenge and long-lived plasma cells that can be found in the bone marrow months after antigen exposure.

Public Health Relevance

Antibody response is the centerpiece of adaptive immunity that is critical for containment of a pathogen. Despite that, our understanding of the biology of plasma cells, the cells responsible for generation of the antibodies and critical players in immune memory, remains fragmentary. Here we propose to generate a tool that will give investigators unprecedented control over gene expression specifically in plasma cells, and we outline experiments aimed at gaining novel insight into how long-lived plasma cells are maintained in the absence of antigen re-exposure.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Exploratory/Developmental Grants (R21)
Project #
5R21AI137752-02
Application #
9822951
Study Section
Cellular and Molecular Immunology - A Study Section (CMIA)
Program Officer
Ferguson, Stacy E
Project Start
2018-11-15
Project End
2020-10-31
Budget Start
2019-11-01
Budget End
2020-10-31
Support Year
2
Fiscal Year
2020
Total Cost
Indirect Cost
Name
New York University
Department
Pathology
Type
Schools of Medicine
DUNS #
121911077
City
New York
State
NY
Country
United States
Zip Code
10016